Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China
文献类型:期刊论文
作者 | Li, Jin2; Shao, Feng3; Zhao, Lingjun4; Zheng, Fei5; Zhu, Hua6; Li, Enchun7; Zhou, Wei8; Yao, Guorong1; Liu, Jie9; Zheng, Jianxiao10 |
刊名 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
![]() |
出版日期 | 2023-11-01 |
卷号 | 33 |
ISSN号 | 1048-891X |
DOI | 10.1136/ijgc-2023-IGCS.104 |
WOS研究方向 | Oncology ; Obstetrics & Gynecology |
语种 | 英语 |
WOS记录号 | WOS:001262421600213 |
出版者 | BMJ PUBLISHING GROUP |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/135893] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Huzhou Cent Hosp, Dept Integrated Chinese & Western Med, Huzhou, Peoples R China 2.Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China 3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Gynecol Surg Dept, Canc Hosp, Hangzhou, Peoples R China 4.Ningbo Women & Childrens Hosp, Dept Gynecol, Ningbo, Peoples R China 5.Ningbo 2 Hosp, Dept Gynecol, Ningbo, Peoples R China 6.Wenzhou Med Univ, Dept Gynecol, Affiliated Hosp 1, Wenzhou, Peoples R China 7.Zhejiang Univ, Dept Gynecol, Womens Hosp, Sch Med, Hangzhou, Peoples R China 8.Taizhou Hosp Zhejiang Prov, Dept Gynecol, Taizhou, Peoples R China 9.Jinhua Peoples Hosp, Dept Gynecol, Jinhua, Peoples R China 10.Yueqing Peoples Hosp, Dept Integrated Chinese & Western Med, Wenzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Jin,Shao, Feng,Zhao, Lingjun,et al. Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,2023,33. |
APA | Li, Jin.,Shao, Feng.,Zhao, Lingjun.,Zheng, Fei.,Zhu, Hua.,...&Wu, Xiaohua.(2023).Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,33. |
MLA | Li, Jin,et al."Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China".INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 33(2023). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。